Linking legal and marketing theories regarding secondary pharma patents

Although the seminar which takes place on the afternoon of Thursday 3 November, 5.00pm to 6.30pm, is officially an IPKat event, its subject matter is one which may appeal to many readers of this weblog too. The speaker is Dr Galit Gonen (head of European patent litigation at Teva Pharmaceuticals) and the title of her paper is "Linkages between legal and marketing theories regarding secondary patents for pharmaceuticals". The venue is the London office of Olswang LLP, 90 High Holborn, where incidentally the IP Finance weblog held its first meeting in January 2008.

A panel of experts will comment briefly on the paper (which is based on Galit’s PhD thesis) before it’s thrown open to the floor for general discussion. Mr Justice Arnold (Patents Court, England and Wales), Professor Jo Gibson (Intellectual Property Institute and Queen Mary Intellectual Property Research Institute) and Chris Stothers (IBIL and Arnold & Porter) will be there and it is hoped that the Intellectual Property Institute's Economics Unit will also be represented.

Refreshments will be provided and registration is free. If you'd like to attend, please email Jeremy at the IPKat here and tell him. He will acknowledge your email when he can.